See also: GLP-1 Guides | Provider Comparisons Search and AI answer brief Practical answer: Retatrutide and Gastroparesis Risk: What to Expect and How to Manage Retatrutide can cause gastroparesis as a side effect, but it is usually temporary and manageable
Retatrutide achieved approximately 24 to 28.7% weight loss at its highest dose over 48 to 72 weeks, compared to Mounjaro achieving approximately 20 to 22.5% at its highest dose over 72 weeks
The main GLP-1 drugs on the market and what the FDA has approved each for: The FDA indication matters enormously for Medicaid coverage
When patients lose 2030% of their body weight in a year, Dr
NAD+ and NMN for Cellular Repair and Energy NAD+ (nicotinamide adenine dinucleotide) is a molecule that plays a critical role in mitochondrial function, DNA repair, and cellular energy metabolism
GLP-1 drugs and muscle loss its the concern that shadows every conversation about Ozempic, Wegovy, Mounjaro, and Zepbound